Strengthening Access to Essential Medicines in Jamaica

A health system strengthening initiative advancing medication supply resilience, governance-aligned pharmaceutical capacity, and preparedness planning to support continuity of care across Jamaica and the Caribbean.

Early development phase • Governance-first model • Regulatory alignment • Institutional partnerships

Why medication supply resilience matters

Jamaica’s health system faces structural vulnerabilities in medication access due to import dependency, global supply disruptions, procurement lead times, and limited localized pharmaceutical capacity.

These constraints can impact continuity of care, particularly for chronic disease management and emergency response.

Strengthening pharmaceutical resilience and preparedness is essential to ensuring reliable access to essential medicines.

What are we building

RxJamaica Health Solutions applies a system-level approach to strengthening pharmaceutical resilience and continuity of care built on 3-pillars:

Localized compounding pathways
Development of governance-aligned pathways to address prioritized medication gaps and shortage scenarios.

Governance & quality systems
Design of oversight frameworks, documentation standards, and quality systems to ensure regulatory alignment and patient safety.

Institutional integration
Collaboration with public-sector stakeholders, providers, and academic institutions to support preparedness and continuity-of-care planning.

Supporting measurable health system outcomes

The initiative is designed to support measurable outcomes across the health system:

  • Improved access to essential medicines

  • Reduced vulnerability to supply disruptions

  • Strengthened health system resilience

  • Enhanced emergency preparedness capacity

  • Improved continuity of care

Aligned with national priorities and global health frameworks

RxJamaica Health Solutions supports the objectives of Vision 2030 Jamaica by contributing to:

  • Strengthening health system resilience

  • Improving access to essential medicines

  • Enhancing preparedness for public health emergencies

  • Supporting sustainable healthcare delivery

The initiative is designed to complement national strategies and institutional priorities.

Early development phase

The initiative is currently focused on governance design, regulatory alignment, stakeholder engagement, and implementation planning.

RxJamaica Health Solutions is not currently providing clinical or pharmaceutical services.

Clarity of scope

RxJamaica Health Solutions is:

  • Not a retail pharmacy

  • Not currently operating a compounding facility

  • Not an industrial pharmaceutical manufacturer

The initiative is focused on system-level planning, governance, and preparedness.

Collaboration pathways

RxJamaica Health Solutions is designed for collaboration across the health system.

Public Sector (MoHW, NHF, RHAs)
Preparedness integration, essential medicines prioritization, and policy alignment

Healthcare Providers
Continuity-of-care planning and shortage response coordination

Academic Institutions
Workforce development and training

Donors & Philanthropies
Capacity building, technical assistance, and system strengthening support